Publications 2023

Myhre PL, Berge T, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Solheim S, Arnesen H, Seljeflot I, Tveit A (2023)
Omega-3 fatty acid supplements and risk of atrial fibrillation and 'micro-atrial fibrillation': A secondary analysis from the OMEMI trial
Clin Nutr, 42 (9), 1657-1660
DOI 10.1016/j.clnu.2023.07.002, PubMed 37515843

Nilsen DWT, Myhre PL, Solheim S, Tveit SH, Kalstad AA, Laake K, Tveit A, Seljeflot I (2023)
Total Bilirubin Yields Prognostic Information Following a Myocardial Infarction in the Elderly
Antioxidants (Basel), 12 (6)
DOI 10.3390/antiox12061157, PubMed 37371887

Warlo EMK, Kalstad AA, Myhre PL, Solheim S, Arnesen H, Tveit A, Holme PA, Seljeflot I, Bratseth V (2023)
von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction
Res Pract Thromb Haemost, 7 (4), 100164
DOI 10.1016/j.rpth.2023.100164, PubMed 37255854

Publications 2022

Berge T, Myhre PL, Kalstad AA, Laake K, Tveit SH, Onarheim S, Solheim S, Seljeflot I, Arnesen H, Tveit A (2022)
Screen-Detected Atrial Fibrillation and "Micro-Atrial Fibrillation" and Risk of Cardiovascular Events after Myocardial Infarction in Elderly Patients
Cardiology, 148 (1), 72-77
DOI 10.1159/000528726, PubMed 36538900

Myhre PL, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Solheim S, Arnesen H, Seljeflot I (2022)
Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial
J Intern Med, 291 (5), 637-647
DOI 10.1111/joim.13442, PubMed 34982486

Opstad TB, Solheim S, Pettersen AR, Kalstad AA, Arnesen H, Seljeflot I (2022)
TERT and TET2 Genetic Variants Affect Leukocyte Telomere Length and Clinical Outcome in Coronary Artery Disease Patients-A Possible Link to Clonal Hematopoiesis
Biomedicines, 10 (8)
DOI 10.3390/biomedicines10082027, PubMed 36009574

Publications 2021

Kalstad AA, Myhre PL, Laake K, Opstad TB, Tveit A, Solheim S, Arnesen H, Seljeflot I (2021)
Biomarkers of ageing and cardiac remodeling are associated with atrial fibrillation
Scand Cardiovasc J, 55 (4), 213-219
DOI 10.1080/14017431.2021.1889653, PubMed 33650449

Publications 2020

Kalstad AA, Myhre PL, Laake K, Tveit SH, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Fagerland MW, Solheim S, Seljeflot I, Arnesen H, OMEMI Investigators (2020)
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial
Circulation, 143 (6), 528-539
DOI 10.1161/CIRCULATIONAHA.120.052209, PubMed 33191772

Opstad TB, Kalstad AA, Holte KB, Berg TJ, Solheim S, Arnesen H, Seljeflot I (2020)
Shorter Leukocyte Telomere Lengths in Healthy Relatives of Patients with Coronary Heart Disease
Rejuvenation Res, 23 (4), 324-332
DOI 10.1089/rej.2019.2258, PubMed 31805818

Publications 2019

Kalstad AA, Tveit S, Myhre PL, Laake K, Opstad TB, Tveit A, Schmidt EB, Solheim S, Arnesen H, Seljeflot I (2019)
Leukocyte telomere length and serum polyunsaturated fatty acids, dietary habits, cardiovascular risk factors and features of myocardial infarction in elderly patients
BMC Geriatr, 19 (1), 376
DOI 10.1186/s12877-019-1383-9, PubMed 31881852

Opstad TB, Kalstad AA, Pettersen AÅ, Arnesen H, Seljeflot I (2019)
Novel biomolecules of ageing, sex differences and potential underlying mechanisms of telomere shortening in coronary artery disease
Exp Gerontol, 119, 53-60
DOI 10.1016/j.exger.2019.01.020, PubMed 30684534